bioRxivImmunology
Development of a high-throughput bead based assay system to measure HIV-1 specific immune signatures in clinical samples
T. Liechti, C. Kadelka, H. Ebner, N. Friedrich, R. D. Kouyos, H. F. Gunthard, A. Trkola
Abstract
The monitoring and assessment of a broadly neutralizing antibody (bnAb) based HIV-1 vaccine require detailed measurements of HIV-1 binding antibody responses to support the detection of correlates of protection. Here we describe the development of a flexible, high-throughput microsphere based multiplex assay system that allows monitoring complex binding antibody signatures. Studying a panel of 13 HIV-1 antigens in a parallel assessment of different IgG subclasses (IgG1, IgG2 and IgG3) we demonstrate the potential of our strategy. The technical advances we describe include means to improve antigen reactivity using directed neutravidin-biotin immobilization of antigens and biotin saturation to reduce background. A particular emphasis of our study was to provide tools for the assessment of reproducibility and stability of the assay system and strategies to control for variations allowing the application in high-throughput assays, where reliability of single measurements needs to be guaranteed.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential
Bette Korber, Michael S. Seaman, … Elena E. Giorgi·PLoS PathogensPeer-reviewed·Apr 23, 2026
- Anti-Immune Complex Antibodies are Elicited During Repeated Immunization with HIV Env Immunogens
S. Brown, A. Antanasijevic, … A. B. Ward·bioRxiv·Mar 15, 2024
- Contemporary HIV-1 consensus Env with redesigned hypervariable loops promote antibody binding
H. Bai, E. Lewitus, … M. Rolland·bioRxiv·Nov 19, 2023
- Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy
Lutz Gieselmann, Andrew T. DeLaitsch, … Florian Klein·bioRxiv·Aug 27, 2025
- Sequential vaccination matures VRC01-class HIV-1 neutralizing antibodies in humans
Tom G. Caniels, Madhu S. Prabhakaran, … Rogier W. Sanders·bioRxiv·Oct 26, 2026
- CD4 binding-site antibodies induced by a subtype B HIV-1 envelope trimer
A. Schorcht, T. L. G. M. van den Kerkhof, … R. W. Sanders·bioRxiv·Mar 23, 2022